company background image
JTL

Jayex TechnologyASX:JTL Stock Report

Market Cap

AU$6.2m

7D

8.7%

1Y

-34.2%

Updated

26 Oct, 2021

Data

Company Financials
JTL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

JTL Overview

Jayex Technology Limited develops and provides healthcare industry service technologies and integrated dispensing automation systems for the pharmaceutical and healthcare sectors in Australia and the United Kingdom.

Price History & Performance

Summary of all time highs, changes and price drops for Jayex Technology
Historical stock prices
Current Share PriceAU$0.025
52 Week HighAU$0.021
52 Week LowAU$0.06
Beta1.28
1 Month Change0%
3 Month Change-7.41%
1 Year Change-34.21%
3 Year Change13.64%
5 Year Change-46.81%
Change since IPO-91.53%

Recent News & Updates

Sep 14
Is Jayex Technology (ASX:JTL) Using Debt In A Risky Way?

Is Jayex Technology (ASX:JTL) Using Debt In A Risky Way?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

JTLAU Healthcare ServicesAU Market
7D8.7%3.3%0.8%
1Y-34.2%46.5%24.4%

Return vs Industry: JTL underperformed the Australian Healthcare Services industry which returned 46.5% over the past year.

Return vs Market: JTL underperformed the Australian Market which returned 24.4% over the past year.

Price Volatility

Is JTL's price volatile compared to industry and market?
JTL volatility
JTL Beta1.28
Industry Beta0.48
Market Beta1

Stable Share Price: JTL is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: JTL's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2006n/an/ahttps://www.jayex.com/en-au/

Jayex Technology Limited develops and provides healthcare industry service technologies and integrated dispensing automation systems for the pharmaceutical and healthcare sectors in Australia and the United Kingdom. It offers Jayex Connect platform, a cloud-based patient engagement platform, which allow users for appointment booking, patient calling, patient check-in, health messaging, and script management. Its products also include Jayex antimicrobial screen covers; and Enlighten, a patient check-in kiosk.

Jayex Technology Fundamentals Summary

How do Jayex Technology's earnings and revenue compare to its market cap?
JTL fundamental statistics
Market CapAU$6.23m
Earnings (TTM)-AU$2.42m
Revenue (TTM)AU$4.99m

1.3x

P/S Ratio

-2.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
JTL income statement (TTM)
RevenueAU$4.99m
Cost of RevenueAU$4.04m
Gross ProfitAU$943.00k
ExpensesAU$3.36m
Earnings-AU$2.42m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.0097
Gross Margin18.92%
Net Profit Margin-48.50%
Debt/Equity Ratio262.6%

How did JTL perform over the long term?

See historical performance and comparison

Valuation

Is Jayex Technology undervalued compared to its fair value and its price relative to the market?

3.21x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate JTL's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate JTL's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: JTL is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.

PE vs Market: JTL is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate JTL's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: JTL is good value based on its PB Ratio (3.2x) compared to the AU Healthcare Services industry average (4.1x).


Future Growth

How is Jayex Technology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

40.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jayex Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Jayex Technology performed over the past 5 years?

38.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: JTL is currently unprofitable.

Growing Profit Margin: JTL is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: JTL is unprofitable, but has reduced losses over the past 5 years at a rate of 38.2% per year.

Accelerating Growth: Unable to compare JTL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: JTL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (37.7%).


Return on Equity

High ROE: JTL has a negative Return on Equity (-124.7%), as it is currently unprofitable.


Financial Health

How is Jayex Technology's financial position?


Financial Position Analysis

Short Term Liabilities: JTL's short term assets (A$4.0M) do not cover its short term liabilities (A$6.2M).

Long Term Liabilities: JTL's short term assets (A$4.0M) exceed its long term liabilities (A$3.2M).


Debt to Equity History and Analysis

Debt Level: JTL's debt to equity ratio (262.6%) is considered high.

Reducing Debt: JTL's debt to equity ratio has increased from 0.03% to 262.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: JTL has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: JTL has less than a year of cash runway if free cash flow continues to grow at historical rates of 16.6% each year.


Dividend

What is Jayex Technology current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate JTL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate JTL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if JTL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if JTL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of JTL's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.2yrs

Average management tenure


CEO

Jayex Technology has no CEO, or we have no data on them.


Leadership Team

Experienced Management: JTL's management team is considered experienced (3.2 years average tenure).


Board Members

Experienced Board: JTL's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.8%.


Top Shareholders

Company Information

Jayex Technology Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Jayex Technology Limited
  • Ticker: JTL
  • Exchange: ASX
  • Founded: 2006
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$6.231m
  • Shares outstanding: 249.23m
  • Website: https://www.jayex.com/en-au/

Number of Employees


Location

  • Jayex Technology Limited
  • 17B Cribb Street
  • Milton
  • Queensland
  • 4064
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 07:02
End of Day Share Price2021/10/26 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.